Jávorszky Ödön Kórház

Vác H-2600

1 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndrome, Chronic Idiopathic Constipation, Coronary Artery Disease, Crohn's Disease, Moderately to Severely Active Ulcerative Colitis, Myocardial Infarction, Percutaneous Coronary Intervention, Prostate Cancer, Ulcerative Colitis

Studies at this site

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: — Recruiting now
• A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) — Running, not enrolling
• A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) — Completed
• An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis — Completed
• Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis — Stopped early
• Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation — Stopped early
• A Degarelix Trial in Patients With Prostate Cancer — Stopped early
• A Trial of Degarelix in Patients With Prostate Cancer — Completed
• Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) — Stopped early